Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.4K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.5K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.5K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.1K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.0K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.0K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

486
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
486
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

3.2K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating cytological images and spatial transcriptomics for cell segmentation with DISSECT.

Nature computational science·2026
Same author

Organic Chemistry as a Catalyst for AI Innovation: Challenges, Methods, and Emerging Paradigms.

Chemical reviews·2026
Same author

Optical fibre gripper for high-performance 3D micromanipulation.

Nature·2026
Same author

Efficacy and safety of FangJiHuangQi granule in patients with heart failure: a protocol of randomized, placebo-controlled trial.

Frontiers in cardiovascular medicine·2026
Same author

REGγ Links Inflammation to Fibrosis in Post-Necrotizing Enterocolitis Intestinal Strictures by Activating Transforming Growth Factor-β/Smad3 Signaling.

The American journal of pathology·2026
Same author

Hierarchical and Ultrametric Barriers in the Energy Landscape of Jammed Granular Matter.

Physical review letters·2026

Related Experiment Video

Updated: Aug 19, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.7K

Multisource Attention-Mechanism-Based Encoder-Decoder Model for Predicting Drug-Drug Interaction Events.

Deng Pan1, Lijun Quan1,2,3, Zhi Jin1

  • 1School of Computer Science and Technology, Soochow University, Suzhou215006, China.

Journal of Chemical Information and Modeling
|November 30, 2022
PubMed
Summary

We developed novel attention-based models, MAEDDI and MAEDDIE, to predict drug-drug interactions (DDIs) and associated events by integrating multisource drug features. These models offer improved drug representation and prediction accuracy for complex DDI relationships.

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

502
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K

Related Experiment Videos

Last Updated: Aug 19, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.7K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

502
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K

Area of Science:

  • Computational chemistry
  • Pharmacology
  • Bioinformatics

Background:

  • Drug-drug interactions (DDIs) pose significant clinical challenges.
  • Existing computational methods often rely on limited, single-source drug features, hindering accurate prediction.
  • Effective drug representation is crucial for understanding and predicting complex interactions.

Purpose of the Study:

  • To propose novel attention-mechanism-based encoder-decoder models for predicting DDIs and DDI-associated events.
  • To enhance drug representation by incorporating multisource information.
  • To improve the accuracy and generalization of DDI prediction models.

Main Methods:

  • Developed two models: MAEDDI for DDI prediction and MAEDDIE for DDI-associated event prediction.
  • Integrated multisource drug features using sequence-based, structural, biochemical, and statistical data.
  • Employed self-attention, cross-attention, and graph attention networks for feature fusion.
  • Constructed a multisource feature fusion network for comprehensive drug representation.

Main Results:

  • MAEDDI and MAEDDIE outperformed state-of-the-art methods in DDI and DDI-associated event prediction tasks.
  • Visualization analysis confirmed effective semantic feature learning and good drug representation.
  • MAEDDIE successfully identified 43 DDI events for favipiravir with high accuracy.
  • The models demonstrated strong generalization capabilities in predictions.

Conclusions:

  • Multisource feature integration and attention mechanisms significantly improve DDI prediction accuracy.
  • The proposed models provide a robust framework for characterizing complex drug-drug relationships.
  • These computational tools can aid in screening potential DDI events and enhancing drug safety.